The 2 Minute Medicine® Podcast

We begin with a discussion about our article of the week from JAMA, entitled “Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes”  In the second half of the episode, we begin with talking about a pioneering immunotherapy approach for brain cancer. Then we discuss the advantages of access to over-the-counter birth control. After that, we take a look at abortion ban rulings issued by the Florida Supreme Court. Finally, we go over cardiac pacemakers and how they have changed over time. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin with a discussion about our article of the week entitled “Electronic nicotine delivery systems for smoking cessation. In the second half of the episode, we discuss Kate Middleton’s recent cancer diagnosis and have a conversation about cancer trends that have recently made the news. Next, we follow with a discussion about the first person to undergo kidney transplantation from a genetically altered pig, take a closer look at the solar eclipse and its impact on eye health, and conclude with a conversation about lab-grown meat and what the research has shown so far.

In this episode, we begin with a discussion about our article of the week entitled “An umbrella review and meta-analysis of meta-analyses of the impact of Ramadan fasting on the metabolic syndrome components“. Next, we talk about a new cure strategy for HIV. Then we discuss issues revolving around psychotropic polypharmacy in youth. After that, we take a look at a new method to improve IVF treatments. Finally, we go over the recent cyberattack at UnitedHealth’s Change Healthcare and its consequences.

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.” Then we discuss the challenges and recovery after having brain aneurysm and talk about the first disease modifying FDA approved drug for Alzheimer’s disease. After that, we take a look at liver transplant in children. Finally, we go over psoriasis and briefly go over risk factors and treatments.

We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Apixaban for stroke prevention in subclinical atrial fibrillation”. In the second half of the episode, we begin with a discussion about stroke in young patients with Lupus. Then we discuss how Starting January 29th British Columbia began providing Canada’s first-at-home self HPV screening test kits for cervical cancer. Last but not least, we take a closer look at acne, current treatments, and a possible vaccine that has shown promise in mouse models, and conclude with a conversation about opioids.

We begin this episode by discussing our article of the week which comes from the BMC Nutrition Journal and is entitled “Clusters of carbohydrate-rich foods and associations with type 2 diabetes incidence: a prospective cohort study.” We begin with a discussion about blood donation, and the decline we are seeing in blood donors. Then we take a closer look at lead poisoning in the context of a recent recall of contaminated cinnamon applesauce products. After that, we investigate multiple sclerosis and how it can affect one’s life. Finally, we discuss the cold winter temperatures, the risks of the cold, and how we can stay safe this winter.

In this episode, we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Teplizumab and beta-cell function in newly diagnosed type 1 diabetes.” Then we take a closer look at allergies and new treatments on the horizon for food allergies. Next, a discussion about lung cancer, following the recent passing of Andre Braugher. Last but not least, we discuss New Year’s resolutions along with evidence-based ways to make them last and explore the rise in cases of counterfeit Ozempic use, and how this has affected the world. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the Annals of Internal Medicine and is entitled “Cardiovascular health of middle-aged US adults by income level, 1999 to March 2020: A serial cross-sectional study.” In the second half, we begin by discussing an increasingly popular procedure used in infants who are struggling with breastfeeding. Then we delve into the new findings that a hormone, GDF15, is linked to morning sickness. After this, we discuss ketamine, the drug that was implicated in the tragic passing of 'Friends' star Matthew Perry. Finally, we end with a conversation about the ongoing generic drug shortages occurring across the country.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of  gonorrhea, Zoliflodacin. Last but not least, we discuss why ⁠March of Dimes⁠, a maternal and infant health organization, issued ⁠a D+ to the USA⁠ for the 2nd year in a row for its relatively high rate of preterm births.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠⁠https://bit.ly/2zZnJt9⁠

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠https://bit.ly/2zZnJt9